Department of Pharmaceutical Sciences, Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, FL, USA.
Handb Exp Pharmacol. 2022;271:115-135. doi: 10.1007/164_2020_395.
The kappa opioid receptor (KOR) is a G protein-coupled receptor (GPCR) that can signal through multiple signaling pathways. KOR agonists are known to relieve pain and itch, as well as induce dysphoria, sedation, hallucinations, and diuresis. As is the case with many other GPCRs, specific signaling pathways downstream of the KOR have been linked to certain physiological responses induced by the receptor. Those studies motivated the search and discovery of a number of KOR ligands that preferentially activate one signaling pathway over another. Such compounds are termed functionally selective or biased ligands, and may present a way of inducing desired receptor effects with reduced adverse reactions. In this chapter, I review the molecular intricacies of KOR signaling and discuss the studies that have used biased signaling through the KOR as a way to selectively modulate in vivo physiology.
κ 阿片受体(KOR)是一种 G 蛋白偶联受体(GPCR),可通过多种信号通路传递信号。已知 KOR 激动剂可缓解疼痛和瘙痒,同时还会引起烦躁、镇静、幻觉和利尿。与许多其他 GPCR 一样,KOR 下游的特定信号通路与受体引起的某些生理反应有关。这些研究促使人们寻找和发现了许多 KOR 配体,这些配体优先激活一种信号通路而不是另一种。这些化合物被称为功能选择性或偏向性配体,它们可能为诱导所需的受体效应而减少不良反应提供了一种方法。在本章中,我将回顾 KOR 信号传递的分子复杂性,并讨论使用 KOR 偏向性信号传递来选择性调节体内生理学的研究。